Can Aztekin

发表

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival

Nurcan Tuncbag, A. Cribbs, T. Onder, 2023, Cell Communication and Signaling.